These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1411 related articles for article (PubMed ID: 11944939)

  • 1. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.
    Zhang H; Fujitani Y; Wright CV; Gannon M
    Genesis; 2005 Jul; 42(3):210-7. PubMed ID: 15986486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
    Chiba H; Chambon P; Metzger D
    Exp Cell Res; 2000 Nov; 260(2):334-9. PubMed ID: 11035928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase.
    Danielian PS; Muccino D; Rowitch DH; Michael SK; McMahon AP
    Curr Biol; 1998 Dec; 8(24):1323-6. PubMed ID: 9843687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.
    Qiu HY; Guo C; Cheng XW; Huang Y; Xiong ZQ; Ding YQ
    Genesis; 2008 Jun; 46(6):324-8. PubMed ID: 18543300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional tamoxifen Cre induced mutagenesis in the embryonic kidney in organ culture.
    Jokela T; Vainio S
    Genesis; 2007 Dec; 45(12):757-61. PubMed ID: 18064673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system.
    Bradley CK; Takano EA; Göthert JR; Göttgens B; Green AR; Begley CG; van Eekelen JA
    Genesis; 2007 Mar; 45(3):145-51. PubMed ID: 17330263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible site-specific recombination in the brain.
    Kellendonk C; Tronche F; Casanova E; Anlag K; Opherk C; Schütz G
    J Mol Biol; 1999 Jan; 285(1):175-82. PubMed ID: 9878397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-inducible Cre-mediated recombination in adipocytes.
    Sassmann A; Offermanns S; Wettschureck N
    Genesis; 2010 Oct; 48(10):618-25. PubMed ID: 20715175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse tool for conditional mutagenesis in ovarian granulosa cells.
    Grabner B; Blaas L; Musteanu M; Hoffmann T; Birbach A; Eferl R; Casanova E
    Genesis; 2010 Oct; 48(10):612-7. PubMed ID: 20715176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
    Heidmann D; Lehner CF
    Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-activated Flpe for temporally regulated gene modifications.
    Hunter NL; Awatramani RB; Farley FW; Dymecki SM
    Genesis; 2005 Mar; 41(3):99-109. PubMed ID: 15729687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity.
    Kemp R; Ireland H; Clayton E; Houghton C; Howard L; Winton DJ
    Nucleic Acids Res; 2004; 32(11):e92. PubMed ID: 15247325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.